Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19

DOI record: { "DOI": "10.1007/s10654-022-00891-4", "ISSN": [ "0393-2990", "1573-7284" ], "URL": "http://dx.doi.org/10.1007/s10654-022-00891-4", "alternative-id": [ "891" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "31 January 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "16 June 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "9 August 2022" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Competing Interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors have no relevant financial or non-financial interests to disclose." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "affiliation": [], "family": "García-Albéniz", "given": "Xabier", "sequence": "first" }, { "affiliation": [], "family": "del Amo", "given": "Julia", "sequence": "additional" }, { "affiliation": [], "family": "Polo", "given": "Rosa", "sequence": "additional" }, { "affiliation": [], "family": "Morales-Asencio", "given": "José Miguel", "sequence": "additional" }, { "affiliation": [], "family": "Hernán", "given": "Miguel A", "sequence": "additional" } ], "container-title": "European Journal of Epidemiology", "container-title-short": "Eur J Epidemiol", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 8, 9 ] ], "date-time": "2022-08-09T08:02:38Z", "timestamp": 1660032158000 }, "deposited": { "date-parts": [ [ 2022, 8, 9 ] ], "date-time": "2022-08-09T09:05:22Z", "timestamp": 1660035922000 }, "indexed": { "date-parts": [ [ 2022, 8, 10 ] ], "date-time": "2022-08-10T04:18:34Z", "timestamp": 1660105114906 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 8, 9 ] ] }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 8, 9 ] ], "date-time": "2022-08-09T00:00:00Z", "timestamp": 1660003200000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 8, 9 ] ], "date-time": "2022-08-09T00:00:00Z", "timestamp": 1660003200000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s10654-022-00891-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s10654-022-00891-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s10654-022-00891-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1007", "published": { "date-parts": [ [ 2022, 8, 9 ] ] }, "published-online": { "date-parts": [ [ 2022, 8, 9 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "891_CR1", "unstructured": "Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, et al. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. medRxiv. 2020:2020.10.15.20209817." }, { "DOI": "10.1056/NEJMoa2022926", "author": "P Horby", "doi-asserted-by": "publisher", "first-page": "2030", "issue": "21", "journal-title": "N Engl J Med", "key": "891_CR2", "unstructured": "Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, et al. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020;383(21):2030–40.", "volume": "383", "year": "2020" }, { "DOI": "10.1016/j.onehlt.2020.100141", "doi-asserted-by": "crossref", "key": "891_CR3", "unstructured": "Bienvenu AL, Marty AM, Jones MK, Picot S. Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020. One health (Amsterdam, Netherlands). 2020;10:100141." }, { "DOI": "10.1056/NEJMoa2016638", "author": "DR Boulware", "doi-asserted-by": "publisher", "first-page": "517", "issue": "6", "journal-title": "N Engl J Med", "key": "891_CR4", "unstructured": "Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517–25.", "volume": "383", "year": "2020" }, { "key": "891_CR5", "unstructured": "Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, et al. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. New England Journal of Medicine; 2020." }, { "DOI": "10.1093/cid/ciaa1707", "author": "JD Goldman", "doi-asserted-by": "publisher", "first-page": "e844-e7", "issue": "11", "journal-title": "Clin Infect diseases: official publication Infect Dis Soc Am", "key": "891_CR6", "unstructured": "Goldman JD. Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic. Clin Infect diseases: official publication Infect Dis Soc Am. 2021;72(11):e844-e7.", "volume": "72", "year": "2021" }, { "DOI": "10.1101/2020.09.29.20203869", "doi-asserted-by": "crossref", "key": "891_CR7", "unstructured": "García-Albéniz X, Amo Jd, Polo R, Morales-Asencio JM, Hernán MA. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19. medRxiv. 2022:2020.09.29.20203869." }, { "DOI": "10.1136/bmj.l4898", "author": "JAC Sterne", "doi-asserted-by": "publisher", "first-page": "l4898", "journal-title": "BMJ", "key": "891_CR8", "unstructured": "Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.", "volume": "366", "year": "2019" }, { "DOI": "10.1016/0197-2456(86)90046-2", "author": "R DerSimonian", "doi-asserted-by": "publisher", "first-page": "177", "issue": "3", "journal-title": "Control Clin Trials", "key": "891_CR9", "unstructured": "DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.", "volume": "7", "year": "1986" }, { "DOI": "10.1002/sim.1009", "author": "J Hartung", "doi-asserted-by": "publisher", "first-page": "3875", "issue": "24", "journal-title": "Stat Med", "key": "891_CR10", "unstructured": "Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20(24):3875–89.", "volume": "20", "year": "2001" }, { "DOI": "10.1186/1471-2288-14-25", "author": "J IntHout", "doi-asserted-by": "publisher", "first-page": "25", "issue": "1", "journal-title": "BMC Med Res Methodol", "key": "891_CR11", "unstructured": "IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.", "volume": "14", "year": "2014" }, { "DOI": "10.1002/sim.6879", "author": "A Wiksten", "doi-asserted-by": "publisher", "first-page": "2503", "issue": "15", "journal-title": "Stat Med", "key": "891_CR12", "unstructured": "Wiksten A, Rücker G, Schwarzer G. Hartung-Knapp method is not always conservative compared with fixed-effect meta-analysis. Stat Med. 2016;35(15):2503–15.", "volume": "35", "year": "2016" }, { "DOI": "10.1002/sim.7411", "author": "D Jackson", "doi-asserted-by": "publisher", "first-page": "3923", "issue": "25", "journal-title": "Stat Med", "key": "891_CR13", "unstructured": "Jackson D, Law M, Rücker G, Schwarzer G. The Hartung-Knapp modification for random-effects meta-analysis: A useful refinement but are there any residual concerns? Stat Med. 2017;36(25):3923–34.", "volume": "36", "year": "2017" }, { "DOI": "10.1186/s12874-015-0091-1", "author": "C Röver", "doi-asserted-by": "publisher", "first-page": "99", "issue": "1", "journal-title": "BMC Med Res Methodol", "key": "891_CR14", "unstructured": "Röver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol. 2015;15(1):99.", "volume": "15", "year": "2015" }, { "DOI": "10.1002/sim.7140", "author": "C Partlett", "doi-asserted-by": "publisher", "first-page": "301", "issue": "2", "journal-title": "Stat Med", "key": "891_CR15", "unstructured": "Partlett C, Riley RD. Random effects meta-analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation. Stat Med. 2017;36(2):301–17.", "volume": "36", "year": "2017" }, { "DOI": "10.1111/j.1467-985X.2008.00552.x", "author": "JP Higgins", "doi-asserted-by": "publisher", "first-page": "137", "issue": "1", "journal-title": "J R Stat Soc Ser A Stat Soc", "key": "891_CR16", "unstructured": "Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172(1):137–59.", "volume": "172", "year": "2009" }, { "DOI": "10.1186/s13063-021-05758-9", "author": "B Grau-Pujol", "doi-asserted-by": "publisher", "first-page": "808", "issue": "1", "journal-title": "Trials", "key": "891_CR17", "unstructured": "Grau-Pujol B, Camprubí-Ferrer D, Marti-Soler H, Fernández-Pardos M, Carreras-Abad C, Andrés MV-d, et al. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021;22(1):808.", "volume": "22", "year": "2021" }, { "DOI": "10.1007/s10840-021-00989-x", "doi-asserted-by": "crossref", "key": "891_CR18", "unstructured": "Liu HH, Ezekowitz MD, Columbo M, Khan O, Martin J, Spahr J, et al. Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic. J Interv Card Electrophysiol. 2021:1–12." }, { "author": "R Rajasingham", "key": "891_CR19", "unstructured": "Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America; 2020.", "volume-title": "Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial", "year": "2020" }, { "DOI": "10.1001/jamainternmed.2020.6319", "doi-asserted-by": "crossref", "key": "891_CR20", "unstructured": "Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, et al. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA internal medicine; 2020." }, { "DOI": "10.1016/j.ijid.2021.04.035", "author": "RCS Seet", "doi-asserted-by": "publisher", "first-page": "314", "journal-title": "Int J Infect Dis", "key": "891_CR21", "unstructured": "Seet RCS, Quek AML, Ooi DSQ, Sengupta S, Lakshminarasappa SR, Koo CY, et al. Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial. Int J Infect Dis. 2021;106:314–22.", "volume": "106", "year": "2021" }, { "DOI": "10.1101/2021.05.17.21257012", "doi-asserted-by": "crossref", "key": "891_CR22", "unstructured": "Syed F, Arif MA, Niazi R, Baqar JB, Hashmi UL, Batool S, et al. Pre-Exposure Prophylaxis with Various Doses of Hdroxychloroquine among high-risk COVID 19 Healthcare Personnel: CHEER randomized controlled trial. medRxiv. 2021:2021.05.17.21257012." }, { "DOI": "10.1101/2021.08.19.21262275", "doi-asserted-by": "crossref", "key": "891_CR23", "unstructured": "Naggie S, Milstone A, Castro M, Collins SP, Seetha L, Anderson DJ, et al. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial (HERO-HCQ). medRxiv. 2021:2021.08.19.21262275." }, { "DOI": "10.1101/2022.03.02.22271710", "doi-asserted-by": "crossref", "key": "891_CR24", "unstructured": "Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño M, et al. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers. medRxiv. 2022:2022.03.02.22271710." }, { "DOI": "10.1371/journal.pone.0261980", "author": "J Rojas-Serrano", "doi-asserted-by": "publisher", "first-page": "e0261980", "issue": "2", "journal-title": "PLoS ONE", "key": "891_CR25", "unstructured": "Rojas-Serrano J, Portillo-Vásquez AM, Thirion-Romero I, Vázquez-Pérez J, Mejía-Nepomuceno F, Ramírez-Venegas A, et al. Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial. PLoS ONE. 2022;17(2):e0261980.", "volume": "17", "year": "2022" }, { "key": "891_CR26", "unstructured": "Barnabas RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, Johnston C, Thorpe LE, et al. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial. Ann Intern Med. 2020." }, { "DOI": "10.1016/j.ijid.2021.12.343", "author": "JE McKinnon", "doi-asserted-by": "publisher", "first-page": "167", "journal-title": "Int J Infect Dis", "key": "891_CR27", "unstructured": "McKinnon JE, Wang DD, Zervos M, Saval M, Marshall-Nightengale L, Kilgore P, et al. Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study. Int J Infect Dis. 2022;116:167–73.", "volume": "116", "year": "2022" }, { "key": "891_CR28", "unstructured": "Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et al. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis." }, { "author": "[Consensus Document on post-exposure prophylaxis against HIV", "first-page": "121.e1-15", "issue": "2", "journal-title": "Enferm Infecc Microbiol Clin", "key": "891_CR29", "unstructured": "[Consensus Document on post-exposure prophylaxis against HIV. HBV and HCV in adults and children]. Enferm Infecc Microbiol Clin. 2016;34(2):121.e1-15.", "volume": "34", "year": "2016" }, { "DOI": "10.1093/cid/ciaa237", "author": "X Yao", "doi-asserted-by": "publisher", "first-page": "732", "issue": "15", "journal-title": "Clin Infect diseases: official publication Infect Dis Soc Am", "key": "891_CR30", "unstructured": "Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect diseases: official publication Infect Dis Soc Am. 2020;71(15):732–9.", "volume": "71", "year": "2020" }, { "DOI": "10.1056/NEJMsm1605385", "author": "MA Hernan", "doi-asserted-by": "publisher", "first-page": "1391", "issue": "14", "journal-title": "N Engl J Med", "key": "891_CR31", "unstructured": "Hernan MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl J Med. 2017;377(14):1391–8.", "volume": "377", "year": "2017" }, { "DOI": "10.1097/EDE.0000000000001177", "doi-asserted-by": "crossref", "key": "891_CR32", "unstructured": "Dahabreh IJ, Petito LC, Robertson SE, Hernán MA, Steingrimsson JA. Toward Causally Interpretable Meta-analysis: Transporting Inferences from Multiple Randomized Trials to a New Target Population. Epidemiology (Cambridge, Mass). 2020;31(3):334 – 44." }, { "DOI": "10.1186/s13063-020-04446-4", "author": "RV Barnabas", "doi-asserted-by": "publisher", "first-page": "475", "issue": "1", "journal-title": "Trials", "key": "891_CR33", "unstructured": "Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, et al. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):475.", "volume": "21", "year": "2020" }, { "DOI": "10.1038/d41586-019-00857-9", "author": "V Amrhein", "doi-asserted-by": "publisher", "first-page": "305", "issue": "7748", "journal-title": "Nature", "key": "891_CR34", "unstructured": "Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305–7.", "volume": "567", "year": "2019" }, { "DOI": "10.1007/s10654-016-0149-3", "author": "S Greenland", "doi-asserted-by": "publisher", "first-page": "337", "issue": "4", "journal-title": "Eur J Epidemiol", "key": "891_CR35", "unstructured": "Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–50.", "volume": "31", "year": "2016" }, { "DOI": "10.1038/s41467-021-22446-z", "author": "C Axfors", "doi-asserted-by": "publisher", "first-page": "2349", "issue": "1", "journal-title": "Nat Commun", "key": "891_CR36", "unstructured": "Axfors C, Schmitt AM, Janiaud P, van’t Hooft J, Abd-Elsalam S, Abdo EF, et al. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021;12(1):2349.", "volume": "12", "year": "2021" }, { "DOI": "10.2196/20044", "author": "K Niburski", "doi-asserted-by": "publisher", "first-page": "e20044", "issue": "11", "journal-title": "J Med Internet Res", "key": "891_CR37", "unstructured": "Niburski K, Niburski O. Impact of Trump’s Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study. J Med Internet Res. 2020;22(11):e20044.", "volume": "22", "year": "2020" }, { "author": "JJ Bartoszko", "first-page": "n949-n", "journal-title": "BMJ (Clinical research ed)", "key": "891_CR38", "unstructured": "Bartoszko JJ, Siemieniuk RAC, Kum E, Qasim A, Zeraatkar D, Ge L, et al. Prophylaxis against covid-19: living systematic review and network meta-analysis. BMJ (Clinical research ed). 2021;373:n949-n.", "volume": "373", "year": "2021" } ], "reference-count": 38, "references-count": 38, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s10654-022-00891-4" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Epidemiology" ], "subtitle": [], "title": "Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy" }